The principle of inhibiting DNA repair genes has been proposed for cells that carry mutations in the breast cancer susceptibility genes BRCA1 or BRCA2 as a possible cancer drug target (Farmer et al., 2005). Here, BRCA1 is linked to breast carcinoma.